Psychedelic Drug Trials: Are Your Sites Ready?
Momentum around psychedelic drug development is accelerating, but these studies introduce operational challenges that many traditional CNS sites are not prepared to manage. In this brief article, explore four factors sponsors should consider when evaluating sites:
- Endpoint complexity and specialized assessments
- Structural blinding during treatment sessions
- Patient vulnerability
- Set and Setting protocols
Download the article to learn more.
Download the Article
Flourish Research News
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.